Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Office-Based Screening for Dementia in Parkinson Disease: The Montreal Parkinson Risk of Dementia Scale in 4 Longitudinal Cohorts.

Dawson BK, Fereshtehnejad SM, Anang JBM, Nomura T, Rios-Romenets S, Nakashima K, Gagnon JF, Postuma RB.

JAMA Neurol. 2018 Mar 26. doi: 10.1001/jamaneurol.2018.0254. [Epub ahead of print]

PMID:
29582054
2.

The Value of Pre-Screening in the Alzheimer's Prevention Initiative (API) Autosomal Dominant Alzheimer's Disease Trial.

Rios-Romenets S, Giraldo-Chica M, López H, Piedrahita F, Ramos C, Acosta-Baena N, Muñoz C, Ospina P, Tobón C, Cho W, Ward M, Langbaum JB, Tariot PN, Reiman EM, Lopera F.

J Prev Alzheimers Dis. 2018;5(1):49-54. doi: 10.14283/jpad.2017.44.

PMID:
29405233
3.

Tango for treatment of motor and non-motor manifestations in Parkinson's disease: a randomized control study.

Rios Romenets S, Anang J, Fereshtehnejad SM, Pelletier A, Postuma R.

Complement Ther Med. 2015 Apr;23(2):175-84. doi: 10.1016/j.ctim.2015.01.015. Epub 2015 Feb 9.

PMID:
25847555
4.

Homozygosity of the autosomal dominant Alzheimer disease presenilin 1 E280A mutation.

Kosik KS, Muñoz C, Lopez L, Arcila ML, García G, Madrigal L, Moreno S, Ríos Romenets S, Lopez H, Gutierrez M, Langbaum JB, Cho W, Suliman S, Tariot PN, Ho C, Reiman EM, Lopera F.

Neurology. 2015 Jan 13;84(2):206-8. doi: 10.1212/WNL.0000000000001130. Epub 2014 Dec 3. No abstract available.

5.

Treatment of restless legs syndrome.

Rios Romenets S, Postuma RB.

Curr Treat Options Neurol. 2013 Aug;15(4):396-409. doi: 10.1007/s11940-013-0241-x.

PMID:
23703310
6.

Doxepin and cognitive behavioural therapy for insomnia in patients with Parkinson's disease -- a randomized study.

Rios Romenets S, Creti L, Fichten C, Bailes S, Libman E, Pelletier A, Postuma RB.

Parkinsonism Relat Disord. 2013 Jul;19(7):670-5. doi: 10.1016/j.parkreldis.2013.03.003. Epub 2013 Apr 2.

PMID:
23561946
7.

Restless legs syndrome outside the blood-brain barrier--exacerbation by domperidone in Parkinson's disease.

Rios Romenets S, Dauvilliers Y, Cochen De Cock V, Carlander B, Bayard S, Galatas C, Wolfson C, Postuma RB.

Parkinsonism Relat Disord. 2013 Jan;19(1):92-4. doi: 10.1016/j.parkreldis.2012.07.019. Epub 2012 Aug 24.

PMID:
22922159
8.

Caffeine for treatment of Parkinson disease: a randomized controlled trial.

Postuma RB, Lang AE, Munhoz RP, Charland K, Pelletier A, Moscovich M, Filla L, Zanatta D, Rios Romenets S, Altman R, Chuang R, Shah B.

Neurology. 2012 Aug 14;79(7):651-8. doi: 10.1212/WNL.0b013e318263570d. Epub 2012 Aug 1. Erratum in: Neurology. 2012 Oct 16;79(16):1744.

9.

Rapid eye movement sleep behavior disorder and risk of dementia in Parkinson's disease: a prospective study.

Postuma RB, Bertrand JA, Montplaisir J, Desjardins C, Vendette M, Rios Romenets S, Panisset M, Gagnon JF.

Mov Disord. 2012 May;27(6):720-6. doi: 10.1002/mds.24939. Epub 2012 Feb 9.

PMID:
22322798
10.

[Pharmacotherapy of the cognitive sequelae secondary to traumatic brain injury].

Riós-Romenets S, Castaño-Monsalve B, Bernabeu-Guitart M.

Rev Neurol. 2007 Nov 1-15;45(9):563-70. Review. Spanish.

11.

[Semantic dementia: a case report].

Ríos-Romenets S, Tirado V, Arbeláez A, Ríos A, Lopera F.

Rev Neurol. 2005 Feb 16-28;40(4):253-4. Spanish. No abstract available.

Supplemental Content

Loading ...
Support Center